Bank of America’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History
Bought
Maintained
Sold
Other funds holding LABD
IC
BFM
TRCT
VF
TSS
SRL
Bank of America's LABD Position: Q3 2025 in Review
Bank of America sold out of Direxion Daily S&P Biotech Bear 3X ETF (LABD) in Q3 2025, closing a stake of 310 shares — an estimated $23.2K sold.
Bank of America first reported a position in LABD in Q2 2020 and held it in 15 quarters. The position peaked at $4M in Q1 2024. 18 funds tracked by Wall St. Rank hold LABD as of Q3 2025.
- Bank of America reported no remaining Direxion Daily S&P Biotech Bear 3X ETF position as of Q3 2025 after selling out during the quarter.
- Bank of America sold 310 Direxion Daily S&P Biotech Bear 3X ETF shares in Q3 2025, an estimated $23.2K.
- Bank of America first reported a position in Direxion Daily S&P Biotech Bear 3X ETF in Q2 2020 and held it in 15 quarters.
- Bank of America's Direxion Daily S&P Biotech Bear 3X ETF position peaked at $4M in Q1 2024.
- 18 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q3 2025.
Based on Bank of America's 13F filing for Q3 2025, filed 14 Nov 2025.